<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01066676</url>
  </required_header>
  <id_info>
    <org_study_id>IV/48.4</org_study_id>
    <nct_id>NCT01066676</nct_id>
  </id_info>
  <brief_title>Dexibuprofen 400 mg Sachet Versus Ibuprofen 400 mg Sachet in Patients With Osteoarthritis of the Hip or Knee</brief_title>
  <official_title>Prospective, Clinical Trial to Investigate Safety, Tolerability and Efficacy of Dexibuprofen Gebro 400 mg Powder for Oral Suspension (Test) Compared to Ibuprofen 400 mg Powder for Oral Suspension (Reference) in Patients Suffering From Osteoarthritis of the Hip or Knee</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gebro Pharma GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gebro Pharma GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Medical condition under investigation: Osteoarthritis of the hip or knee

      Number of patients planned: 480 adult patients

      Main objective: To evaluate and compare the tolerability profile of Dexibuprofen Gebro 400 mg
      powder for oral suspension compared to Ibuprofen 400 mg in patients with painful
      osteoarthritis of the hip or knee

      Secondary objectives: To compare the overall efficacy of Dexibuprofen Gebro 400 mg powder for
      oral suspension compared to Ibuprofen 400 mg in patients suffering from different complaints
      due to painful osteoarthritis of the hip or knee
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tolerability profile of Dexibuprofen Gebro 400 mg powder for oral suspension compared to Ibuprofen 400 mg in patients with painful osteoarthritis of the hip or knee</measure>
    <time_frame>14 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall efficacy of Dexibuprofen Gebro 400 mg powder for oral suspension compared to Ibuprofen 400 mg in patients suffering from different complaints due to painful osteoarthritis of the hip or knee</measure>
    <time_frame>14 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">482</enrollment>
  <condition>Osteoarthritis of the Hip or Knee</condition>
  <arm_group>
    <arm_group_label>Dexibuprofen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dexibuprofen 400 mg powder for oral suspension</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ibuprofen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ibuprofen 400 mg powder for oral suspension</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexibuprofen</intervention_name>
    <description>400mg powder for oral suspension, daily dose 800mg</description>
    <arm_group_label>Dexibuprofen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen</intervention_name>
    <description>400mg, powder for oral suspension, daily dose 1600mg</description>
    <arm_group_label>Ibuprofen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male or female patients aged between 18 and 75 years

          -  everyday joint pain for the past three months

          -  global pain intensity in the involved joint (hip or knee) of &quot;moderate&quot; to &quot;severe&quot;
             within the last 48 h

        Exclusion Criteria:

          -  acute inflammation or ischaemic necrosis

          -  paget's disease, chondrocalcinosis, ochronosis of the hip/knee joint

          -  slowly progressing hip/knee arthropathy in particular of tuberculosis aetiology

          -  hip/knee arthropathy due to diabetes mellitus

          -  Charcot's joint

          -  villous synovitis

          -  chondromatosis of the synovium

          -  patients with existing gastritis or existing ulcers or bleedings in the
             gastrointestinal tract or patients with history of gastrointestinal ulcers or
             gastrointestinal haemorrhage in the past 6 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Reinhold Hawel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rehabilitationszentrum, Bad Hofgastein</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rehabzentrum f√ºr Erkrankungen des rheumat. Formenkreises</name>
      <address>
        <city>Bad Hofgastein</city>
        <state>Salzburg</state>
        <zip>5630</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rheuma Zentrum Favoriten</name>
      <address>
        <city>Vienna</city>
        <zip>1100</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <link>
    <url>http://www.gebro.com</url>
  </link>
  <verification_date>July 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 9, 2010</study_first_submitted>
  <study_first_submitted_qc>February 9, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 10, 2010</study_first_posted>
  <last_update_submitted>July 9, 2012</last_update_submitted>
  <last_update_submitted_qc>July 9, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 10, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Hip</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

